Wellmarker Bio Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $361K

  • Investors
  • 27

Wellmarker Bio General Information

Description

Developer of anticancer drugs designed to treat cancer patients with medical advancements. The company specializes in developing predictive biomarkers and first-in-class drugs through profound research know-how and a research Institute that comprises a target discovery department, drug discovery department, and medicinal chemistry department, enabling healthcare providers to cure their patients and improve their lives.

Contact Information

Website
www.wmbio.co
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 947 Hanam-daero
  • 808 S-dong Pungsan-dong, Hanam Techno Valley U1 Center
  • Hanam, Gyeonggi
  • South Korea
+82
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Corporate Office
  • 947 Hanam-daero
  • 808 S-dong Pungsan-dong, Hanam Techno Valley U1 Center
  • Hanam, Gyeonggi
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Wellmarker Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC 31-Jul-2024 $361K Completed Generating Revenue
7. Secondary Transaction - Private Completed Clinical Trials - Phase 1
6. Later Stage VC (Series C) 01-Aug-2021 Completed Clinical Trials - Phase 1
5. Early Stage VC (Series B) 14-Oct-2020 Completed Clinical Trials - Phase 1
4. Early Stage VC (Series B) 05-Jul-2019 Completed Clinical Trials - Phase 1
3. Early Stage VC (Series A) 08-Oct-2018 Completed Clinical Trials - General
2. Seed Round 01-Apr-2018 $4.34M $4.34M Completed Clinical Trials - General
1. Corporate 27-Dec-2016 $2.11K $2.11K Completed Startup
To view Wellmarker Bio’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Wellmarker Bio Patents

Wellmarker Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2024205282-A1 Igsf1-specific binding protein and use thereof Inactive 29-Mar-2023
WO-2024090916-A1 Pharmaceutical composition for cancer treatment comprising anti-igsf1 antibody Inactive 24-Oct-2022
WO-2023229303-A1 Antibody binding to c-terminus of igsf1 and use thereof Inactive 23-May-2022
WO-2023211073-A1 Biomarker composition for predicting cancer patient susceptibility to anti-igsf1 antibody, and method using same Inactive 25-Apr-2022
WO-2023211068-A1 Pharmaceutical composition for cancer treatment, comprising anti-igsf1 antibody and anti-pd-1 antibody Inactive 25-Apr-2022 C07K16/2803
To view Wellmarker Bio’s complete patent history, request access »

Wellmarker Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Wellmarker Bio Investors (27)

Investor Name Investor Type Holding Investor Since Participating Rounds
Elohim Partners PE/Buyout Minority
GeneN Investment Partners Venture Capital Minority
GTOG Private Equity PE/Buyout Minority
Laguna Investment Venture Capital Minority
LS Securities Investment Bank Minority
You’re viewing 5 of 27 investors. Get the full list »

Wellmarker Bio FAQs

  • When was Wellmarker Bio founded?

    Wellmarker Bio was founded in 2016.

  • Where is Wellmarker Bio headquartered?

    Wellmarker Bio is headquartered in Hanam, South Korea.

  • What is the size of Wellmarker Bio?

    Wellmarker Bio has 7 total employees.

  • What industry is Wellmarker Bio in?

    Wellmarker Bio’s primary industry is Drug Discovery.

  • Is Wellmarker Bio a private or public company?

    Wellmarker Bio is a Private company.

  • What is Wellmarker Bio’s current revenue?

    The current revenue for Wellmarker Bio is .

  • How much funding has Wellmarker Bio raised over time?

    Wellmarker Bio has raised $41.8M.

  • Who are Wellmarker Bio’s investors?

    Elohim Partners, GeneN Investment Partners, GTOG Private Equity, Laguna Investment, and LS Securities are 5 of 27 investors who have invested in Wellmarker Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process